BridgeBio Pharma, Inc.

Rhenman & Partners Asset Management AB BBIO

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/14/2026

Shares

90,600

Value ($000)

6,728

Weight

0.8%

2025 Q4 - 2026 Q1 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/14/2026	6,728	0.8%	90,600	3/31/2026
2025 Q4	2/13/2026	6,242	0.6%	81,600	12/31/2025